Indications for an antidepressive effect of thymosin alpha-1 in a small open-label proof of concept study in common variable immune deficiency patients with depression

Background: A considerable proportion (21%) of patients with common variable immunodeficiency (CVID) suffers from depression. These subjects are characterized by reduced naïve T cells and a premature T cell senescence similar to that of patients with major depressive disorder (MDD). It is known that...

Full description

Saved in:

Bibliographic Details
Main Authors:	Daniël G. Aynekulu Mersha, Sarah E. Fromme, Frank van Boven, Gara Arteaga-Henríquez, Annemarie Wijkhuijs, Marianne van der Ent, Raf Berghmans, Bernard T. Baune, Hemmo A. Drexhage, Virgil Dalm
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Brain, Behavior, & Immunity - Health
Subjects:	CVID Depression Thymalfasin Therapy Improvement
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666354624002126
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Indications for an antidepressive effect of thymosin alpha-1 in a small open-label proof of concept study in common variable immune deficiency patients with depression

Similar Items